Kleinostheim, 7 December 2016 – curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States. The innovative product made of resorbable ceramic […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone